{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1044",
  "meta": {
    "versionId": "20",
    "lastUpdated": "2022-03-01T01:04:38.000-05:00"
  },
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Value Set Contents</h3><p>This value set contains 13 concepts</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---snomed.info-sct-786847005\"> </a><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=786847005\">786847005</a></td><td>http://snomed.info/sct</td><td>Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---snomed.info-sct-86198006\"> </a><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=86198006\">86198006</a></td><td>http://snomed.info/sct</td><td>Administration of vaccine product containing only Influenza virus antigen (procedure)</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90655\"> </a>90655</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90657\"> </a>90657</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90661\"> </a>90661</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90662\"> </a>90662</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90673\"> </a>90673</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90674\"> </a>90674</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90685\"> </a>90685</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90686\"> </a>90686</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90687\"> </a>90687</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90688\"> </a>90688</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.ama-assn.org-go-cpt-90756\"> </a>90756</td><td>http://www.ama-assn.org/go/cpt</td><td>Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use</td></tr></table></div>"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044",
  "version": "20170504",
  "name": "Influenza Vaccine Administered",
  "status": "active",
  "date": "2022-03-07T11:14:02-05:00",
  "publisher": "NCQA PHEMUR",
  "expansion": {
    "identifier": "urn:uuid:8d6a6515-7ed2-4a03-a5e7-d0349e43f703",
    "timestamp": "2022-07-19T15:07:51-04:00",
    "total": 13,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20220301",
      "code": "786847005",
      "display": "Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure)"
    }, {
      "system": "http://snomed.info/sct",
      "version": "http://snomed.info/sct/731000124108/version/20220301",
      "code": "86198006",
      "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90655",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90657",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90661",
      "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90662",
      "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90673",
      "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90674",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90685",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90686",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90687",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90688",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90756",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
    } ]
  }
}